Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: Agonists and antagonists

Human Reproduction

Volumn 14, Issue SUPPL. 1, 1999, Pages 207-221

  Felberbaum, R ^a   Diedrich, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

GnRH antagonists; OHSS; Ovarian stimulation; Premature LH surge

Indexed keywords

BUSERELIN; CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE;

CLINICAL PROTOCOL; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; INTRANASAL DRUG ADMINISTRATION; LUTEINIZING HORMONE RELEASE; OVARY DISEASE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032884514     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.suppl_1.207     Document Type: Conference Paper

References (45)

1. Adashi, E.Y. (1994) Endocrinology of the ovary. Hum. Reprod., 9 (Suppl, 2), 36-51.
2. Albano, C., Smitz, J., Camus, M. et al. (1996) Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix). Hum. Reprod., 11, 2114-2118.
3. Albano, C., Smitz, J., Camus, M. et al. (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil. Steril., 67, 917-922.
4. Balen, A. (1995) The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction. Hum. Reprod., 10, 2233-2237.
5. Bauer, O. and Diedrich, K. (1996) Komplikationen der assistierten Reproduktion. Gynäkologe, 29, 464-473.
6. Cassidenti, D.L., Sauer, M.V., Paulson, R.J. et al. (1991) Comparison of intermittent and continuous use of gonadotrophin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report. Am. J. Obstet. Gynecol., 165, 1806-1810.
7. Chappel, S.C. and Howles, C. (1991) Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum. Reprod., 6, 1206-1212.
8. de Jong, D., Macklon, N.S., Mannaerts, B.M.J.L. et al. (1998) Case report: high dose gonadotrophin-releasing hormone antagonist (Ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization. Hum. Reprod., 13, 573-575.
9. Deutsches IVF Register, Jahrbuch 1997. Available from: DIR Bundesgeschäftsstelle Ärztekammer Schleswig Holstein, Bismarckallee 8-12, 23795 Bad Segeberg, Germany.
10. Diedrich, K., Diedrich, C., Santos, E. et al. (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum. Reprod., 9, 788-791.
11. Dittkoff, E.C., Cassidenti, D.L., Paulson, R.J. et al. (1991) The gonadotrophin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am. J. Obstet. Gynecol., 165, 1811-1817.
12. Duijkers, I.J.M., Klipping, C., Willemsen, W.N.P. et al. (1998) Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers. Hum. Reprod., 13 (Abstract book 1), 123.
13. Edwards, R.G., Lobo, R. and Bouchard, P. (1996) Time to revolutionize ovarian stimulation. Hum. Reprod., 11, 917-919.
14. ®). GynecoL Endocrinol., 13 (Suppl. 1) 13.
15. Felberbaum, R.E. (1999) Cetrorelix in controlled ovarian stimulation for ART: results of phase III, multiple dose treatment. Gynecol. Endocrinol., 13 (Suppl. 1), 14.
16. Felberbaum, R.E., Reissmann, T., Küpker, W. et al. (1995) Preserved pituitary response under ovarian stimulation with HMG and GnRH-antagonists (Cetrorelix) in women with tubal infertility. Eur. J. Obstet. Gynecol. Reprod. Biol., 61, 151-155.
17. Felberbaum, R., Reissmann, T., Kupker, W. et al. (1996) Hormone profiles under ovarian stimulation with human menopausal gonadotrophin (HMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages. J. Assist. Reprod. Genet, 13, 216-222.
18. Felberbaum, R., Montzka, P., Küpker, W. et al. (1997) High fertilization rate after ovarian stimulation with clomiphene citrate for ICSI. Hum. Reprod., 12 (Abstract book 1), 150.
19. Felberbaum, R.E., Ortmann, O., Eick, F. et al. (1998) GnRH-Antagonist (Cetrorelix) used for COH in vivo does not impair sexual steroid secretion of granulosa lutein cells in vitro. Fertil. Sleril., 70/3 (Suppl. 1), S109.
20. Frydman, R., Cornel, C. and de Ziegler, D. (1991) Prevention of premature luteinizing hormone and progesterone rise with gonadotrophin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation. Fertil. Steril., 56, 923-927.
21. ®). Hum. Reprod., 13, 3023-3031.
22. Golan, A., Ron-El, R., Herman, A. et al. (1988) Ovarian hyperstimulation syndrome following D-Trp-6-luteinizing hormone-releasing hormone microcapsules and menotropins for in vitro fertilization. Fertil. Steril., 50, 912-916.
23. Küpker, W., Al-Hasani, S., Schulze, W. et al. (1995) Morphology in intracytoplasmic sperm injection: preliminary results. J. Assist. Reprod. Genet., 12, 620-626.
24. Loumaye, E. (1990) The control of endogenous secretion of luteinizing hormone by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum. Reprod., 5, 357-376.
25. Loumaye, E., de Cooman, S., Anoma, M. et al. (1988) Short term utilization of a gonadotropin releasing hormone agonist (Buserelin) for induction of ovulation in an in-vitro fertilization program. Ann. N.Y. Acad. Sci., 541, 96-102.
26. Loumaye, E., Porchet, H.C., Beltrami, V. et al. (1994) Ovulation induction with recombinant human follicle-stimulating hormone and luteinizing hormone. In Filicori, M. and Flamigni, C. (eds), Ovulation Induction. Basic Science and Clinical Advances. Elsevier Science, The Netherlands, pp. 227-236.
27. Macnamee, M.C., Howles, C.M., Edwards, R.G. et al. (1989) Short term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization. Fertil. Steril., 52, 264-269.
28. ®). Gynecol. Endocrinol., 13 (Suppl. 1), 12.
29. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1994) The single or dual administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer programme. Fertil. Steril., 62, 468-476.
30. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1995) Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum. Reprod., 10, 1382-1386.
31. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1996) Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertil. Steril., 66, 151-153.
32. Olivennes, F., Belaisch-Allart, J., Emperaire, J.C. et al. (1999) Comparison in a prospective multicentric randomized study in IVF-ET of a single dose of GnRH antagonist (Cetrorelix) to a GnRH agonist long protocol (Triptoreline in depot formula). Gynecol. Endocrinol., 13 (Suppl. 1), 14.
33. Ortmann, O., Oltmanns, K., Weiss, J.M. et al. (1998) Effects of the GnRH antagonist Cetrorelix on steroidogenesis in human granulosa lutein cells. Hum. Reprod., 13 (Abstract book 1), 254.
34. Ortmann, O., Weiss, J., Gürke, E.M. et al. (1999) Ovarian effects of GnRH antagonists. Gynecol. Endocrinol., 13 (Suppl. 1), 51.
35. Palermo, G., Joris, H., Devroey, P. and Van Steirteghem, A.C. (1992) Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet, 340, 17-18.
36. Recombinant Human FSH Study Group (1995) Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development for in-vitro fertilization. Fertil. Steril., 63, 77-86.
37. Reissmann, T., Felberbaum, R., Diedrich, K. et al. (1995) Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Hum. Reprod., 10, 1974-1981.
38. Ron-El, R., Herman, A., Golan, A. et al. (1991) Gonadotropins and combined gonadotropin-releasing hormone agonist-gonadotropins protocols in a randomized prospective study. Fertil. Steril., 55, 574-578.
39. School, D.C., Harlin, J., Shoham, Z. et al. (1994) Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum. Reprod., 9, 1237-1242.
40. Smitz, J., Ron-El, R. and Tarlatzis, B.C. (1992) The use of gonadotrophin-releasing hormone agonists for in-vitro fertilization and other assisted procreation techniques: experience from three centres. Hum. Reprod., 7 (Suppl. 1), 49-66.
41. Sommer, L., Diedrich, K. and Klingmuller, D. (1993) Effects of the GnRH-antagonist Cetrorelix in normal women. In Lunenfeld, B. and Insler, V. (eds), GnRH Analogues: the State of the Art 1993. Gynecol. Endocrinol., 7 (Suppl. 2), 20.
42. Stanger, J.D. and Yovich, J.L. (1985) Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br. J. Obstet. Gynaecol., 92, 385-393.
43. Tan, S.L. (1991) Gonadotrophin-releasing hormone agonists in assisted reproductive therapy. J. Br. Fertil. Soc., 1, 137-142.
44. Van Steirteghem, A.C. (1994) IVF and micromanipulation techniques for male-factor infertility. Curr. Opin. Obstet. Gynecol., 6, 173-177.
45. WHO Scientific Group Report (1976) Agent stimulating gonadal function in the Human. World Health Organization. Technical Report Series No. 514. WHO consultation on the diagnosis and treatment of endocrine forms of female infertility.